Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mL. (Q46731793)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mL. |
scientific article |
Statements
1 reference
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mL. (English)
1 reference
Eric Berthelet
1 reference
Tom Pickles
1 reference
Kenny Won Jae Lee
1 reference
Mitchell Liu
1 reference
Pauline T Truong
1 reference
Prostate Cancer Outcomes Initiative
1 reference
1 November 2005
1 reference
63
1 reference
3
1 reference
781-787
1 reference